Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksModel.php on line 57

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksController.php on line 62

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksController.php on line 64

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksController.php on line 66

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView.php on line 122

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView.php on line 125

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Settings.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Keyphrases.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Statistics.php on line 16

Deprecated: Assigning the return value of new by reference is deprecated in /home3/arian/public_html/alimtatreatment/wp-content/plugins/alinks/classes/aLinksView_Modules.php on line 16
alimta pemetrexed mesothelioma



European CHMP issues positive opinion on extending license of …

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion recommending the extension of the license of pemetrexed (Alimta®) to include the first line treatment in …

More: continued here




   Posted in mesothelioma    

Subscribe RSS 2.0 feed. Leave a response, or Trackback from your own site.






Leave a Reply